Company intelligence / Profile preview

SonoClear

Ownership: Private
Development stage: Preclinical

Overview

SonoClear has developed a sterile, advanced acoustic couplant designed to improve the diagnostic accuracy of intraoperative ultrasound imaging. The product has demonstrated safety and performance in two clinical trials compared to standard of care, specifically enhancing tumor border visualization during brain tumor resections[1][4][5].

Therapeutic areas: OncologyNeurologyOther
Modalities: Device
Industry: Medical Imaging

Partnerships

manufacturing agreement with a leading global manufacturer pending as of early/mid 2025[4]

Beyond the preview

Go deeper on SonoClear.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SonoClear.

Explore the full profile